Learn
Articles and quizzes on healthcare AI, regulation, and responsible innovation.
Follow the curated paths below — designed for Hong Kong clinicians, pharmacists, and healthcare administrators building responsible AI literacy step by step.
Curated learning paths
Three guided tracks based on EMA guidance, from everyday LLM use to medicines lifecycle regulation.
Start here: Responsible AI in daily practice
Build foundational AI literacy with EMA's network strategy and practical guidance for using large language models safely in clinical, pharmacy, and administrative work.
- Step 1EMA's AI Strategy for Medicines RegulationHow the European medicines regulatory network plans to harness AI while managing risks — and what Hong Kong healthcare professionals can learn from its 2025–2028 workplan.Read article →
- Step 2Using Large Language Models Responsibly in HealthcareEMA's four guiding principles for safe LLM use — adapted for Hong Kong clinicians, pharmacists, and administrators who draft, summarise, or research with AI tools.Read article →
International standards & regulatory milestones
Understand joint EMA–FDA principles for AI in medicines development and how regulators are validating AI-assisted evidence.
- Step 1EMA & FDA: Ten Principles for Good AI PracticeJoint international principles for using AI across the medicines lifecycle — from early research and clinical trials to manufacturing and safety monitoring.Read article →
- Step 2AI Regulatory Milestones: Qualification & ObservatoryFrom EMA's first AI methodology qualification (AIM-NASH) to the 2024 AI Observatory — what these milestones mean for evidence standards and AI literacy.Read article →
Deep dive: AI across the medicines lifecycle
Work through EMA's reflection paper in order — from general principles and lifecycle stages to regulatory interactions, technical expectations, and governance.
- Step 1EMA AI Reflection Paper: Introduction & General PrinciplesHow the European Medicines Agency frames AI and machine learning in medicines regulation, and the risk-based principles that apply across the lifecycle.Read article →
- Step 2AI Across the Medicinal Product LifecycleEMA guidance on using AI from drug discovery and clinical trials through manufacturing, product information, and post-authorisation pharmacovigilance.Read article →
- Step 3Regulatory Interactions for AI in MedicinesWhen and how to engage EMA through the Innovation Task Force, scientific advice, and qualification of novel methodologies for AI/ML.Read article →
- Step 4Technical Aspects of AI/ML for MedicinesEMA expectations for data acquisition, model development, performance assessment, explainability, and deployment of AI in regulated settings.Read article →
- Step 5Governance, Data Protection & Trustworthy AIEMA guidance on GxP governance, GDPR compliance, data integrity, and EU trustworthy AI principles for medicinal products.Read article →
IMDRF Good Machine Learning Practice for medical devices
Work through IMDRF's ten guiding principles for AI-enabled medical devices — from intended use and data validation to human–AI teamwork, transparency, and real-world monitoring.
- Step 1IMDRF Good Machine Learning Practice: IntroductionWhy international regulators published ten guiding principles for AI-enabled medical devices, and what Hong Kong healthcare professionals should know before using them in practice.Read article →
- Step 2GMLP Principles 1–2: Intended Use & Engineering FoundationsDefine clinically meaningful intended use with multidisciplinary teams, and implement robust software engineering, security, and quality practices across the device lifecycle.Read article →
- Step 3GMLP Principles 3–5: Data, Validation & Reference StandardsEnsure training and test data represent your patient population, maintain independence between datasets, and use fit-for-purpose reference standards.Read article →
- Step 4GMLP Principles 6–7: Model Design & Human–AI TeamsMatch model design to clinical purpose and evaluate performance of the human–AI team in real workflow — not the algorithm alone.Read article →
- Step 5GMLP Principles 8–10: Testing, Transparency & MonitoringValidate AI devices under clinically relevant conditions, provide clear information to users, and monitor deployed models for drift and retraining risks.Read article →
More articles
Additional learning materials outside the curated paths.